Bank of New York Mellon’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Bank of New York Mellon’s Portfolio ONCT Stock Details ONCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-880	Closed	-$5.28K	–	4399
2023 Q3	$5.28K	Hold	880	–	–	﹤0.01%	4317
2023 Q2	$6.07K	Hold	880	–	–	﹤0.01%	4354
2023 Q1	$13.8K	Hold	880	–	–	﹤0.01%	4329
2022 Q4	$17.6K	Hold	880	–	–	﹤0.01%	4369
2022 Q3	$16K	Hold	880	–	–	﹤0.01%	4474
2022 Q2	$20K	Sell	880 -5,941	-87%	-$135K	﹤0.01%	4491
2022 Q1	$190K	Sell	6,821 -182	-3%	-$5.07K	﹤0.01%	4261
2021 Q4	$318K	Buy	7,003 +114	+2%	+$5.18K	﹤0.01%	4061
2021 Q3	$575K	Buy	6,889 +486	+8%	+$40.6K	﹤0.01%	3727
2021 Q2	$608K	Buy	6,403 +5,523	+628%	+$524K	﹤0.01%	3681
2021 Q1	$146K	Sell	880 -90	-9%	-$14.9K	﹤0.01%	4111
2020 Q4	$95K	Buy	+970	New	+$95K	﹤0.01%	4077
2019 Q3	–	Sell	-851	Closed	-$113K	–	4258
2019 Q2	$113K	Buy	851 +737	+646%	+$97.9K	﹤0.01%	4002
2019 Q1	$19K	Sell	114 -1	-0.9%	-$167	﹤0.01%	4155
2018 Q4	$12K	Sell	115 -125	-52%	-$13K	﹤0.01%	4182
2018 Q3	$53K	Buy	240 +19	+9%	+$4.2K	﹤0.01%	4102
2018 Q2	$474K	Buy	221 +53	+32%	+$114K	﹤0.01%	3653
2018 Q1	$417K	Buy	168 +5	+3%	+$12.4K	﹤0.01%	3656
2017 Q4	$291K	Sell	163 -4	-2%	-$7.14K	﹤0.01%	3801
2017 Q3	$197K	Hold	167	–	–	﹤0.01%	3879
2017 Q2	$124K	Buy	+167	New	+$124K	﹤0.01%	3982
2016 Q4	–	Sell	-25	Closed	-$27K	–	4319
2016 Q3	$27K	Sell	25 -3	-11%	-$3.24K	﹤0.01%	4199
2016 Q2	$22K	Hold	28	–	–	﹤0.01%	4258
2016 Q1	$20K	Hold	28	–	–	﹤0.01%	4168
2015 Q4	$28K	Hold	28	–	–	﹤0.01%	4209
2015 Q3	$30K	Hold	28	–	–	﹤0.01%	4243
2015 Q2	$58K	Buy	28 +3	+12%	+$6.21K	﹤0.01%	4140
2015 Q1	$24K	Hold	25	–	–	﹤0.01%	4177
2014 Q4	$25K	Hold	25	–	–	﹤0.01%	4175
2014 Q3	$26K	Hold	25	–	–	﹤0.01%	4175
2014 Q2	$48K	Sell	25 -65	-72%	-$125K	﹤0.01%	4076
2014 Q1	$193K	Hold	90	–	–	﹤0.01%	3837
2013 Q4	$209K	Buy	90 +1	+1%	+$2.32K	﹤0.01%	3813
2013 Q3	$251K	Buy	89 +1	+1%	+$2.82K	﹤0.01%	3702
2013 Q2	$808K	Buy	+88	New	+$808K	﹤0.01%	3290